Clinical Trial Update: Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether HRS9531 affects gastric emptying and the pharmacokinetics of metformin, atorvastatin, warfarin, and digoxin in healthy subjects…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DIGOXIN (Digoxin)
• HRS9531
• Warfarin (warfarin)
• atorvastatin (atorvastatin)
• metformin (metformin)

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED